company background image
IMR logo

Imricor Medical Systems ASX:IMR Stock Report

Last Price

AU$1.66

Market Cap

AU$449.3m

7D

3.1%

1Y

232.0%

Updated

28 May, 2025

Data

Company Financials +

Imricor Medical Systems, Inc.

ASX:IMR Stock Report

Market Cap: AU$449.3m

IMR Stock Overview

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. More details

IMR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Imricor Medical Systems, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Imricor Medical Systems
Historical stock prices
Current Share PriceAU$1.66
52 Week HighAU$1.86
52 Week LowAU$0.41
Beta-0.28
1 Month Change4.73%
3 Month Change5.40%
1 Year Change232.00%
3 Year Change514.81%
5 Year Change30.71%
Change since IPO14.48%

Recent News & Updates

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imricor Medical Systems, Inc.'s (ASX:IMR) CEO For Now

May 08
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imricor Medical Systems, Inc.'s (ASX:IMR) CEO For Now

Does Imricor Medical Systems (ASX:IMR) Have A Healthy Balance Sheet?

Jun 17
Does Imricor Medical Systems (ASX:IMR) Have A Healthy Balance Sheet?

Here's Why Imricor Medical Systems (ASX:IMR) Must Use Its Cash Wisely

Jul 08
Here's Why Imricor Medical Systems (ASX:IMR) Must Use Its Cash Wisely

Will Imricor Medical Systems (ASX:IMR) Spend Its Cash Wisely?

Mar 23
Will Imricor Medical Systems (ASX:IMR) Spend Its Cash Wisely?

We're Hopeful That Imricor Medical Systems (ASX:IMR) Will Use Its Cash Wisely

May 09
We're Hopeful That Imricor Medical Systems (ASX:IMR) Will Use Its Cash Wisely

When Will Imricor Medical Systems, Inc. (ASX:IMR) Turn A Profit?

Feb 28
When Will Imricor Medical Systems, Inc. (ASX:IMR) Turn A Profit?

We Think Imricor Medical Systems (ASX:IMR) Needs To Drive Business Growth Carefully

Jan 24
We Think Imricor Medical Systems (ASX:IMR) Needs To Drive Business Growth Carefully

What Is The Ownership Structure Like For Imricor Medical Systems, Inc. (ASX:IMR)?

Dec 02
What Is The Ownership Structure Like For Imricor Medical Systems, Inc. (ASX:IMR)?

What You Need To Know About Imricor Medical Systems, Inc.'s (ASX:IMR) Investor Composition

Aug 18
What You Need To Know About Imricor Medical Systems, Inc.'s (ASX:IMR) Investor Composition

Shareholder Returns

IMRAU Medical EquipmentAU Market
7D3.1%-0.8%0.2%
1Y232.0%-8.8%7.5%

Return vs Industry: IMR exceeded the Australian Medical Equipment industry which returned -9.8% over the past year.

Return vs Market: IMR exceeded the Australian Market which returned 6.3% over the past year.

Price Volatility

Is IMR's price volatile compared to industry and market?
IMR volatility
IMR Average Weekly Movement11.7%
Medical Equipment Industry Average Movement11.5%
Market Average Movement9.3%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market4.0%

Stable Share Price: IMR has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: IMR's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006n/aSteve Wedanwww.imricor.com

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.

Imricor Medical Systems, Inc. Fundamentals Summary

How do Imricor Medical Systems's earnings and revenue compare to its market cap?
IMR fundamental statistics
Market capAU$449.33m
Earnings (TTM)-AU$46.11m
Revenue (TTM)AU$1.49m
301.6x
P/S Ratio
-9.7x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IMR income statement (TTM)
RevenueUS$959.42k
Cost of RevenueUS$1.88m
Gross Profit-US$924.12k
Other ExpensesUS$28.77m
Earnings-US$29.69m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin-96.32%
Net Profit Margin-3,094.86%
Debt/Equity Ratio-269.3%

How did IMR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 05:17
End of Day Share Price 2025/05/28 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Imricor Medical Systems, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott PowerMorgans Financial Limited